Skip to main content

Table 1 Characteristics of patients and laboratory findings

From: Central hepatopancreatoduodenectomy—oncological effectiveness and parenchymal sparing option for diffusely spreading bile duct cancer: report of two cases

Variables

Case 1

Case 2

Age (years)

66

67

Sex

female

male

BMI (kg/m2)

22.0

23.8

ECOG Performance Status

0

0

Serum bilirubin level at admission (mg/dL)

6.8

14.9

AST (IU/L)

27

268

ALT (IU/L)

25

514

Biliary anatomy

Right antero-ventral bile duct confluent to the right hepatic duct and the right antero-dorsal bile duct independently confluent to the right posterior bile duct

Right posterior bile duct draining into the left hepatic duct

Bismuth-Corlette type

IIIA

IIIA

Serum bilirubin level a day prior to resection (mg/dL)

0.8

1.6

Cumulative Pringle time in operation (min)

62

75

Operative blood loss (mL)

291

890

Total operation time (min)

1158

970

Serum bilirubin (POD 5) (mg/dL)

1.8

1.1

Serum AST/ ALT (POD 5) (mg/dL)

39/137

16/66

PT-INR (POD 5)

0.94

1.0

Clavien-Dindo grading of morbidity

Nil

Grade II—POPF

Staging AJCC (8th edition)

BpBd, flat-infiltrating type, circ, 1.2 × 1.0 × 3.5 cm, pT2, por2, ly(0), v1, ne1, pN0, pDM0, pHM0, pEM0, pPV0, pA0, R0, M0 Stage II

BpBd, papillary invasive type, circ, 1.2 × 0.6 × 7.0 cm, pT1, pap, ly0, v0, ne0, pN0, pDM0, pHM0, pEM0, pPV0, pA0, R0, M0 Stage I

  1. BMI body mass index, ECOG Eastern Cooperative Oncology Group, AST asparate aminotransferase, ALT alanine aminotransferase, POD post operative day, PT-INR prothrombin time international normalized ratio, POPF post operative pancreatic fistula, AJCC American Joint Committee on Cancer